Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46658

1.

CD200-CD200R1 signalling attenuates imiquimod-induced psoriatic inflammation by inhibiting the activation of skin inflammatory macrophages.

Li D, Wang Y, Tang L, Jin X, Xia C, Xu H, Hu J.

Int Immunopharmacol. 2019 Dec 10;78:106046. doi: 10.1016/j.intimp.2019.106046. [Epub ahead of print]

PMID:
31835080
2.

Dendritic cells: The driver of psoriasis.

Wang A, Bai Y.

J Dermatol. 2019 Dec 13. doi: 10.1111/1346-8138.15184. [Epub ahead of print] Review.

PMID:
31833093
3.

Increased presence and differential molecular imprinting of transit amplifying cells in psoriasis.

Witte K, Jürchott K, Christou D, Hecht J, Salinas G, Krüger U, Klein O, Kokolakis G, Witte-Händel E, Mössner R, Volk HD, Wolk K, Sabat R.

J Mol Med (Berl). 2019 Dec 12. doi: 10.1007/s00109-019-01860-3. [Epub ahead of print]

PMID:
31832701
4.

Hydroxyurea-induced cutaneous squamous cell carcinoma: A case report.

Xu Y, Liu J.

World J Clin Cases. 2019 Dec 6;7(23):4091-4097. doi: 10.12998/wjcc.v7.i23.4091.

PMID:
31832413
5.

No evidence for interactions of dimethylfumarate (DMF) and its main metabolite monomethylfumarate (MMF) with human cytochrome P450 (CYP) enzymes and the P-glycoprotein (P-gp) drug transporter.

Aubets J, Jansat JM, Salva M, Birks VM, Cole RJ, Lewis J, Pitcher A, Hall M.

Pharmacol Res Perspect. 2019 Dec 2;7(6):e00540. doi: 10.1002/prp2.540. eCollection 2019 Dec.

PMID:
31832203
6.

The IL17F His161Arg polymorphism, a potential risk locus for psoriasis, increases serum levels of interleukin-17F in an Asian population.

Choi BG, Hong JY, Hong JR, Hur MS, Kim SM, Lee YW, Choe YB, Ahn KJ.

Sci Rep. 2019 Dec 12;9(1):18921. doi: 10.1038/s41598-019-55062-5.

PMID:
31831764
7.

A novel vehicle for the treatment of psoriasis.

Dattola A, Silvestri M, Bennardo L, Passante M, Rizzuto F, Dastoli S, Patruno C, Bianchi L, Nisticò SP.

Dermatol Ther. 2019 Dec 12:e13185. doi: 10.1111/dth.13185. [Epub ahead of print]

PMID:
31830367
8.
9.

Microscopic Examination of Nail Clippings from Patients with Palmoplantar Pustulosis.

Tanaka AA, Werner B, Farris C, Tornesy C.

Dermatopathology (Basel). 2019 Oct 29;6(4):213-219. doi: 10.1159/000503704. eCollection 2019 Oct-Dec.

PMID:
31828062
10.

Mesenchymal Stem Cells Alleviate Moderate-to-Severe Psoriasis by Reducing the Production of Type I Interferon (IFN-I) by Plasmacytoid Dendritic Cells (pDCs).

Chen M, Peng J, Xie Q, Xiao N, Su X, Mei H, Lu Y, Zhou J, Dai Y, Wang S, Li C, Lin G, Cheng L.

Stem Cells Int. 2019 Nov 7;2019:6961052. doi: 10.1155/2019/6961052. eCollection 2019.

PMID:
31827531
11.

Periodontitis: a newly identified comorbidity in psoriasis and psoriatic arthritis.

Dalmády S, Kemény L, Antal M, Gyulai R.

Expert Rev Clin Immunol. 2019 Dec 11:1-8. doi: 10.1080/1744666X.2019.1700113. [Epub ahead of print]

PMID:
31825680
12.

Pediatric Obesity and the Immune System.

Umano GR, Pistone C, Tondina E, Moiraghi A, Lauretta D, Miraglia Del Giudice E, Brambilla I.

Front Pediatr. 2019 Nov 22;7:487. doi: 10.3389/fped.2019.00487. eCollection 2019. Review.

13.

Metabolic Syndrome and Skin Diseases.

Hu Y, Zhu Y, Lian N, Chen M, Bartke A, Yuan R.

Front Endocrinol (Lausanne). 2019 Nov 20;10:788. doi: 10.3389/fendo.2019.00788. eCollection 2019. Review.

14.

Exacerbation of systemic lupus erythematosus in a patient with concomitant chronic plaque psoriasis treated with ustekinumab.

Goh SW, Jamil A, Nor NM, Cader RA, Shaharir SS.

Indian J Dermatol Venereol Leprol. 2019 Dec 11. doi: 10.4103/ijdvl.IJDVL_961_18. [Epub ahead of print] No abstract available.

PMID:
31823905
15.

[Inflammatory Diseases of the Vulva - a Dermatologist's Point of View].

Kolm I.

Praxis (Bern 1994). 2019;108(16):1085-1090. doi: 10.1024/1661-8157/a003330. German.

PMID:
31822232
16.

Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biological agent: A nine-year multicenter cohort study.

Chiu HY, Chiu YM, Chang Liao NF, Chi CC, Tsai TF, Hsieh CY, Hsieh TY, Lai KL, Chiu TM, Wu NL, Hui RC, Lee CN, Wang TS, Chen PH, Yang CC, Huang YH.

J Am Acad Dermatol. 2019 Dec 7. pii: S0190-9622(19)33209-8. doi: 10.1016/j.jaad.2019.12.001. [Epub ahead of print]

PMID:
31821860
17.

Measurement of circulating miRNA-125a exhibits good value in the management of etanercept-treated psoriatic patients.

Pei D, Cao J, Qin G, Wang X.

J Dermatol. 2019 Dec 9. doi: 10.1111/1346-8138.15157. [Epub ahead of print]

PMID:
31820498
18.

Multistate analysis from cross-sectional and auxiliary samples.

Zeng L, Cook RJ, Lee J.

Stat Med. 2019 Dec 10. doi: 10.1002/sim.8411. [Epub ahead of print]

PMID:
31820469
19.

Clinical Features and Genetic Polymorphism in Chinese Patients with Erythrodermic Psoriasis in a Single Dermatologic Clinic.

Lo Y, Chiu HY, Tsai TF.

Mol Diagn Ther. 2019 Dec 9. doi: 10.1007/s40291-019-00441-x. [Epub ahead of print]

PMID:
31820331
20.

Monoclonal Antibodies: Past, Present and Future.

Posner J, Barrington P, Brier T, Datta-Mannan A.

Handb Exp Pharmacol. 2019 Dec 10. doi: 10.1007/164_2019_323. [Epub ahead of print]

PMID:
31820172

Supplemental Content

Loading ...
Support Center